Inventor
PHILIP RAMILA
US24 patents
⚠️ This page may combine multiple inventors who share the name “PHILIP RAMILA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EMERGEX VACCINES HOLDING LTD
11 patentsUS12178867B2Dec 31, 2024
MHC class i associated peptides for prevention and treatment of multiple flavi virus
EMERGEX VACCINES HOLDING LTD0 citations61
US11931407B2Mar 19, 2024
MHC class I associated peptides for prevention and treatment of zika virus
EMERGEX VACCINES HOLDING LTD0 citations61
US11690904B2Jul 4, 2023
MHC class I associated peptides for prevention and treatment of multiple flavi virus
EMERGEX VACCINES HOLDING LTD1 citations61
US11426457B2Aug 30, 2022
MHC class I associated peptides for prevention and treatment of zika virus
EMERGEX VACCINES HOLDING LTD0 citations61
US11344614B2May 31, 2022
Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
EMERGEX VACCINES HOLDING LTD0 citations61
US11273216B2Mar 15, 2022
Universal influenza vaccine compositions
EMERGEX VACCINES HOLDING LTD1 citations61
US11191828B2Dec 7, 2021
MHC class I associated hepatitis B peptides
EMERGEX VACCINES HOLDING LTD0 citations61
US12409215B2Sep 9, 2025
Vaccine compositions
EMERGEX VACCINES HOLDING LTD0 citations55
US12156909B2Dec 3, 2024
Reverse peptide vaccine
EMERGEX VACCINES HOLDING LTD0 citations54
US10155036B2Dec 18, 2018
MHC class I associated peptides for prevention and treatment of hepatitis B virus infection
EMERGEX VACCINES HOLDING LTD0 citations51
US10117922B2Nov 6, 2018
Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine development
EMERGEX VACCINES HOLDING LTD1 citations51
PHILIP RAMILA
4 patentsUS9132178B2Sep 15, 2015
Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
PHILIP RAMILA12 citations82
US9637521B2May 2, 2017
Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection
PHILIP RAMILA3 citations71
US9907842B2Mar 6, 2018
Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
PHILIP RAMILA1 citations50
US9624284B2Apr 18, 2017
Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
PHILIP RAMILA0 citations50
IMMUNOTOPE INC
3 patentsUS7919467B2Apr 5, 2011
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
IMMUNOTOPE INC88 citations93
US7083789B2Aug 1, 2006
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
IMMUNOTOPE INC10 citations69
US10206990B2Feb 19, 2019
Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
IMMUNOTOPE INC0 citations50
RHONE POULENC RORER PHARMA
2 patentsEMERGEX VACCINES HOLDINGS LTD
2 patentsUS10556929B2Feb 11, 2020
Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection
EMERGEX VACCINES HOLDINGS LTD0 citations47
US10144766B2Dec 4, 2018
Cytotoxic T Lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection
EMERGEX VACCINES HOLDINGS LTD0 citations47